DPT Laboratories, a contract development and manufacturing organization, has announced that the company will showcase its aseptic manufacturing capabilities at the Parenteral Drug Association (PDA) annual meeting's exhibit hall on 15-16 March 2010 in Orlando, Florida, US.
This year's PDA meeting theme of 'Manufacturing Excellence' aligns well with DPT's overall philosophy and commitment to customers. The company's aseptic manufacturing capabilities comprise a wide range of sterile dosage forms including small volume parenterals, ophthalmic preparations, nasal sprays and sterile ointments. DPT is suited to provide comprehensive solutions from a state-of-the-art facility to meet customer needs for clinical and small to mid-size commercial batches.
DPT's capabilities for sterile products include:
- Comprehensive development services
- Manufacturing process development
- cGMP manufacturing of clinical trial material (CTM) and commercial product
- Sterile component preparation
- Aseptic filling capabilities for vials (2ml–50ml), micro-dose vials (0.125ml–0.240ml), pre-filled syringes (0.5ml–3.0ml) and tubes (3g-30g)
To learn more about DPT's services, schedule a meeting at the PDA annual meeting or call +1 210 396 5044.
Twitter